Development, characterization and permeability assessment based on Caco-2 monolayers of self-microemulsifying floating tablets of tetrahydrocurcumin

AAPS PharmSciTech

Volumn 14, Issue 1, 2013, Pages 321-331

  Sermkaew, Namfa ^a   Wiwattanawongsa, Kamonthip ^a   Ketjinda, Wichan ^a   Wiwattanapatapee, Ruedeekorn ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Caco 2 cells; controlled release; permeability; self microemulsifying floating tablets; tetrahydrocurcumin

Indexed keywords

CURCUMIN; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; DRUG STORAGE; IN VITRO STUDY; MICROEMULSION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TABLET FORMULATION; TABLET FRIABILITY;

CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMIN; EMULSIONS; HUMANS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; PERMEABILITY; TABLETS;

EID: 84878604925     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9912-2     Document Type: Article

References (37)

1. Yoysungnoen P, Wirachwong P, Changtam C, Suksamran A, Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol. 2008;14(13):2003-9.
2. Murakami Y, Ishii H, Takada N, Tanaka S, Machino M, Ito S, Fujisawa S. Comparative anti-inflammatory activities of curcumin and tetrahydrocurcumin based on the phenolic O-H bond dissociation enthalpy, ionization potential and quantum chemical descriptor. Anticancer Res. 2008;28(2A):699-707.
3. Lai CH, Wu JC, Yu SF, Badmaev V, Nagabhushanam K, Ho CH, Pan MH. Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Mol Nutr Food Res. 2011;55(12):1819-28.
4. Muragan P, Pari L, Rao CA. Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes. J Biosci. 2008;33(1):63-72.
5. Nakmareong S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Kongyingyoes B, Donpunha W, Prachaney P, Phisalaphong C. Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertens Res. 2012;35:418-25.
6. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral bioavailability of lipophilic drugs. Biomed Pharmacother. 2004;58:173-82.
7. Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm. 2009;371:148-55.
8. Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, Meng P, He Z. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm. 2010;383:1-6.
9. Zvonar A, Gasperlin M. Microcapsules with self-emulsifying core: optimization of shell-forming phase. Pharmazie. 2010;65:391-2.
10. Abdalla A, Mäder K. Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm. 2007;66:220-6.
11. Setthacheewakul S, Kedjinda W, Maneenuan D, Wiwattanapatapee R. Controlled release of oral tetrahydrocurcumin from a novel self-emulsifying floating drug delivery system (SEFDDS). AAPS PharmSciTech. 2010;12(1):152-64.
12. Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. Optimization of a self-nanoemulsified tablet dosage form of ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm. 2002;240:103-14.
13. Elkheshen SA, Yassin AEB, Alsuwayeh S, Alkhaled FA. In vitro and in vivo evaluation of floating controlled release dosage forms of verapamil hydrochloride. Pharm Ind. 2004;66(11):1364-72.
14. Chen RN, Ho HO, Yu CY, Sheu MT. Development of swelling/floating gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with CYP2C9 polymorphism. Eur J Pharm Biopharm. 2010;39:82-9.
15. Zhao L, Yang X, Xu R, Wu J, Gu S, Zhang L, Gong P, Chen H, Zang F. Safety, tolerability and pharmacokinetics of phenoprolamine hydrochloride floating sustained-release tablets in healthy Chinese subjects. Int J Pharm. 2009;377:99-104.
16. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS PharmSciTech. 2005;6(3):E372-90.
17. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63:235-59.
18. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee LI, Kim DD, Jee JP, Lee YB, Woo JS, Yong CS, Choi HG. Enhanced oral boioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm. 2009;374:66-72.
19. Motz SA, Schaefer UF, Balbach S, Eichinger T, Lehr CM. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell. Eur J Pharm Biopharm. 2007;66:286-95.
20. Rao SV, Agarwal P, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs II. In vitro transport study. Int J Pharm. 2008;362:10-5.
21. Zvonar A, Berginc K, Kristl A, Gašperlin M. Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide. Int J Pharm. 2010;388:151-8.
22. Hiremath PS, Saha RN. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations. Int J Pharm. 2008;362:118-25.
23. 2 generation by benchtop MRI and its relation to drug release and floating strength. Eur J Pharm Biopharm. 2008;69:708-17.
24. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139-57.
25. Liang WQ, Chow MSS. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release. 2004;95:209-16.
26. Conti S, Maggi L, Segale L, Machisre OM, Conte U, Grenier P, Vergnault G. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. Int J Pharm. 2007;333:136-42.
27. Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm. 2011;77:275-82.
28. Hubatsch I, Ragnarsson EGE, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc. 2007;2(9):2111-9.
29. Wade A, Weller PJ. Handbook of pharmaceutical excipients. 2nd ed. Washington: American Pharmaceutical Association; 1994.
30. Gohel MC. A review of co-processed directly compressible excipients. J Pharm Pharm Sci. 2005;8(1):76-93.
31. Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Technol Today. 2000;3(2):58-63.
32. Arza RAK, Gonugunta CSR, Veerareddy PR. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS PharmSciTech. 2009;10(1):220-6.
33. Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010;74:332-9.
34. Martínez IJ, Barreda TQ, Robles LV. Sustained delivery of captopril from floating matrix tablets. Int J Pharm. 2008;362:37-43.
35. Scherließ R. The MTT assay as tool to evaluate and compare excipient toxicity in vitro on respiratory epithelial cells. Int J Pharm. 2011;411:98-105.
36. Kogan A, Kesselman E, Danino D, Aserin A, Garti N. Viability and permeability across Caco-2 cells of CBZ solubilized in fully dilutable microemulsions. Colloids Surf B. 2008;66:1-12.
37. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth. Pharm Res. 1997;14:763-6.